november AG
november AG publishes Q3 report and nine-months statement for 2004
Ad-hoc-announcement transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
——————————————————————————–
november AG publishes Q3 report and nine-months statement for 2004
Erlangen, 9 November 2004. In the third quarter 2004, the Erlangen (Germany)
based biotech company november AG (ISIN DE0006762909) has continued its
positive development that was already reported after the first six months.
On a nine-months basis, the consolidated revenues rose to 3.800 million EUR
which is a 30% increase compared to the previous year’s period
2.930 million EUR). Due to successfully intensified marketing activities, the
sales and marketing expenses for the past nine months were increased to 1.724
million EUR (previous year’s period: 1.532 million EUR). Within the same
period and reflecting the increased maturity and market readiness of
november’s products, research and development expenses were again
significantly reduced (minus 15%) and totaled 2.113 million EUR
(previous year’s period: 2.492 million EUR).
november AG’s total liquidity after nine months of the financial year 2004 is
still favorable and amounted to 9.074 million EUR (31 December 2003: 12.495
million EUR). Amounting to -3.087 million EUR, the nine-months consolidated
operating result (EBIT) was significantly improved in comparison to the
previous year’s period (-3.512 million EUR). Including financial and tax
result as well as minority interests, the consolidated net result amounts
to -1.917 million EUR, which is a 15% improvement compared to the previous
year’s period (-2.265 million EUR). The balance sheet total at the end of
the third quarter 2004 amounted to 26.969 million EUR (31 December 2003:
28.646 million EUR).
The net earnings per share (EPS and DVFA/SG) improved to EUR -0.26
(previous year’s nine months EPS: EUR -0.33).
On average, 63 employees (recalculated to full-time terms) worked within the
november Group throughout the reporting period from 1 January to 30 September
2004 (previous year’s period: 64 employees). This only includes employees
working in companies that were fully consolidated.
On a quarterly basis, the results are very favorable, too. With consolidated
revenues amounting to 1.542 million EUR (plus 38% compared to the previous
year’s period) and a consolidated operating result (EBIT)
of -0.666 million EUR (improvement by 36% compared to the previous year’s
period) the third quarter of the financial year 2004 was november’s most
successful quarter since the IPO in April 2000.
For additional information, please contact:
Dr. Peer Nils Schröder
november AG – Investor Relations
Ulrich-Schalk-Str. 3, D-91056 Erlangen
Tel.: +49 (0)9131 750 88 868
e-mail: schroeder@november.de, http://www.november.de
end of ad-hoc-announcement (c)DGAP 09.11.2004
——————————————————————————–
WKN: 676290; ISIN: DE0006762909; Index:
Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin-
Bremen, Düsseldorf, Hannover, München und Stuttgart
090832 Nov 04
Latest News
Latest Reports
Upcoming Events
No Events found
Webcasts
No Webcasts found